Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth
Rhea-AI Summary
Astrana Health (NASDAQ: ASTH) was named to the 2026 Fortune 1000, its first appearance on the list of the largest U.S. companies by revenue. In fiscal 2025, revenue reached $3.18 billion, a 56% year-over-year increase.
Astrana reported $205.4 million adjusted EBITDA and $104.5 million free cash flow. The company supports more than 20,000 providers and about 1.55 million patients in value-based care arrangements using AI-enabled, physician-centric care models.
Positive
- 2025 revenue $3.18 billion, up 56% year over year
- Adjusted EBITDA of $205.4 million in fiscal 2025
- Free cash flow of $104.5 million in fiscal 2025
- Added to the 2026 Fortune 1000 list for the first time
- More than 20,000 providers supported in value-based care arrangements
- Approximately 1.55 million patients covered through affiliated networks and clinics
Negative
- None.
News Market Reaction – ASTH
In the Jun 5 session, ASTH gained 0.37%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 12 | Leadership appointment | Positive | +1.9% | Named Interim National Medical Director to oversee population health initiatives. |
| May 11 | Strategic collaboration | Positive | +2.7% | Partnered with Physician Association of California on AI-powered Medicare ACO platform. |
| May 07 | Earnings report | Positive | +8.9% | Q1 2026 revenue and EBITDA grew strongly with reaffirmed 2026 guidance. |
| Apr 21 | Earnings scheduling | Neutral | +3.5% | Announced date and call details for upcoming Q1 2026 results release. |
| Apr 10 | Investor conferences | Neutral | -2.1% | Planned participation in several healthcare investor conferences and fireside chats. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news with clear operational or financial positives (earnings, partnerships, leadership updates) has generally been followed by positive price reactions.
Over the past few months, Astrana has reported strong Q1 2026 results with revenue of $965.1M and notable growth in full-risk value-based arrangements, supported by a detailed 10-Q and reinforcing guidance. The company has remained visible with investor conferences and an updated corporate presentation. Management changes, including an interim National Medical Director, show ongoing evolution of clinical leadership. Today’s Fortune 1000 recognition builds on this trajectory of scale and financial growth highlighted in prior earnings disclosures.
Key Terms
fortune 1000 financial
adjusted ebitda financial
value-based care medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
In fiscal year 2025, Astrana generated revenue of
Today, Astrana supports more than 20,000 providers and approximately 1.55 million patients in value-based care arrangements through its affiliated provider networks, management services organization, and integrated care delivery clinics spanning primary, specialty, and ancillary care.
"Being named to the Fortune 1000 reflects the incredible work our team, physicians, and partners do every day to improve care for patients," said Brandon Sim, President and Chief Executive Officer of Astrana Health. "We believe the future of healthcare will be increasingly AI-enabled, physician-centric, and outcomes-driven. This recognition reflects the progress we've made and reinforces our commitment to building the technology and clinical infrastructure needed to help providers deliver better outcomes at scale."
As healthcare continues to shift toward accountable and outcomes-based care, Astrana remains focused on empowering providers with the technology, clinical support, and aligned incentives needed to improve outcomes and expand access to high-quality care. By bringing together AI-enabled infrastructure, physician-centric care models, and value-based care operations, the Company is helping build a healthcare system that is more proactive, coordinated, and patient-centered.
The Fortune 1000 is Fortune magazine's annual ranking of the 1,000 largest
About Astrana Health, Inc.
Astrana Health is a physician-centric, AI-powered healthcare company committed to delivering high-quality, patient-centered care. Built from the physician's perspective, Astrana combines its scalable care delivery infrastructure, proprietary technology platform, and aligned provider networks to enable proactive, preventive care at scale - improving patient outcomes, enhancing patient experiences, supporting provider well-being, and driving greater value across the healthcare system.
Today, Astrana supports more than 20,000 providers and approximately 1.55 million patients in value-based care arrangements through its affiliated provider networks, management services organization, and integrated care delivery clinics spanning primary, specialty, and ancillary care. Together, Astrana is building the healthcare system we all deserve - one that delivers better care, better experiences, and better outcomes for all. For more information, visit www.astranahealth.com.
FOR MORE INFORMATION, PLEASE CONTACT:
Investor Relations
investors@astranahealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/astrana-health-named-to-the-2026-fortune-1000-list-following-strong-revenue-growth-302792041.html
SOURCE Astrana Health, Inc.